EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Effect of Nusinersen on Respiratory and Bulbar Function in Children with Spinal Muscular Atrophy: Real-World Experience from a Single Center

Mirella Gaboli iD, Mercedes López Lobato, Justo Valverde Fernández, Patricia Ferrand Ferri, Eloisa Rubio Pérez, Henry A Andrade Ruiz, José María López-Puerta González, Marcos Madruga-Garrido

Neuropediatrics · 01.02.2025 · 56 (01) · 002-011

DOI: 10.1055/a-2379-7069 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Neuropediatrics, erschienen am 01.02.2025. Verfasst von Mirella Gaboli und 7 weiteren Autor:innen. Beteiligte Einrichtung: Paediatric Pulmonology Unit, Department of Paediatrics, Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/CSIC/Univer…. Hauptthemen laut MEDLINE: Oligonucleotides, Spinal Muscular Atrophies of Childhood. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Due to the limited data from clinical trials and real-world settings in the realm of nusinersen, there is a need for further evidence. This study seeks to assess the impact of nusinersen, when combined with standard care, on bulbar function, respiratory function, and the necessity for respiratory support among pediatric patients with spinal muscular atrophy (SMA).

Methods

Prospective observational study, involving pediatric SMA patients (Types 1–3) undergoing nusinersen treatment at the Hospital Universitario Virgen del Rocío in Spain over at least 24 months. The cohort included 11 SMA type 1 patients, comprising 6 type 1b and 5 type 1c, 12 SMA type 2 patients, and 5 SMA type 3 patients.

Results

Twenty-eight pediatric patients were enrolled with the majority being male (n = 20). Patients with type 1 were diagnosed and received treatment significantly earlier than those with types 2 and 3 (p < 0.001). Additionally, there was a longer period between diagnosis and the start of treatment in types 2 and 3 (p = 0.002). Follow-up revealed statistically improved functional and respiratory outcomes associated with earlier initiation of nusinersen treatment at 6, 12, and 24 months in all phenotypes. The ability to swallow and feed correctly remained unchanged throughout the study, with SMA type 1c patients maintaining oral feeding in contrast to patients with SMA type 1b. Notably, no deaths were recorded.

Conclusions

This study provides important insights into the real-world clinical progress of pediatric SMA patients and their response to nusinersen treatment, highlighting the significance of early intervention for better functional and respiratory outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OligonucleotidesSpinal Muscular Atrophies of ChildhoodHumansMaleFemaleChild, PreschoolInfantProspective StudiesChild

Substanzen

nusinersenOligonucleotides

Autor:innen und Institutionen

  • Paediatric Pulmonology Unit, Department of Paediatrics, Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain.
  • Paediatric Neurology Unit, Department of Paediatrics, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Paediatric Gastroenterology, Hepatology and Nutrition Unit, Department of Paediatrics, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Paediatric Physical Medicine and Rehabilitation Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Methodological and Statistical Management Unit, Fundación para la Gestión de la Investigación en Salud de Sevilla (FISEVI), Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Spine Surgery, Department of Orthopaedic Surgery and Traumatology, Universitary Hospital Virgen del Rocío, Networking Biomedical Research Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Sevilla, Spa…

ORCID-Profile: Mirella Gaboli

Zitieren

APA

Gaboli, M., López Lobato, M., Valverde Fernández, J., Ferrand Ferri, P., Rubio Pérez, E., Andrade Ruiz, H. A., López-Puerta González, J. M., & Madruga-Garrido, M. (2025). Effect of Nusinersen on Respiratory and Bulbar Function in Children with Spinal Muscular Atrophy: Real-World Experience from a Single Center. Neuropediatrics, 56(01), 002-011. https://doi.org/10.1055/a-2379-7069

Vancouver

Gaboli M, López Lobato M, Valverde Fernández J, Ferrand Ferri P, Rubio Pérez E, Andrade Ruiz HA, et al. Effect of Nusinersen on Respiratory and Bulbar Function in Children with Spinal Muscular Atrophy: Real-World Experience from a Single Center. Neuropediatrics. 2025;56(01):002-011. doi:10.1055/a-2379-7069

BibTeX
@article{Gaboli2025,
  author = {Gaboli, Mirella and López Lobato, Mercedes and Valverde Fernández, Justo and Ferrand Ferri, Patricia and Rubio Pérez, Eloisa and Andrade Ruiz, Henry A and López-Puerta González, José María and Madruga-Garrido, Marcos},
  title = {Effect of Nusinersen on Respiratory and Bulbar Function in Children with Spinal Muscular Atrophy: Real-World Experience from a Single Center},
  journal = {Neuropediatrics},
  year = {2025},
  volume = {56},
  number = {01},
  pages = {002--011},
  doi = {10.1055/a-2379-7069}
}
Kostenlos starten →